Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fixed-Dose Antiplatelet Dual Combination in Patients with Coronary Artery Disease in Turkish Population: DAPT-TR.
Öz A, Toprak K, Aydin E, Saraç İ, Doğduş M, Opan S, Yenerçağ M, Tascanov MB, Kümet Ö, Karaağaç M, Özmen M, Murat B, Kertmen Ö, Bekler Ö, İnci S, Huyut MA, Özderya A, Er F, Duran M, Ardahanlı İ, Baş MM, Güzel T, Ceyhun G, Özdemir İH, Özen MB, Gündüz R, Erdoğan A, Çetin İ, Barış VÖ, Yayla Ç, Karaduman M, Aşkın L, Bekar L, Tanrıverdi O, Özkan E, Yeşil E, Çalışkan S, Kuzu Z, Uğuz B, Böyük F, Kunak AÜ, Murat S, Asil S, Kayhan Ö, Erdoğan E, Duz R, Katkat F, Ekin T, İbişoğlu E, Ateş BN, Ayça B, Ergene AO, Zoghi M. Öz A, et al. Among authors: baris vo. Arq Bras Cardiol. 2024 Oct;121(11):e20240202. doi: 10.36660/abc.20240202. Arq Bras Cardiol. 2024. PMID: 39607170 Free PMC article. English, Portuguese.
Empagliflozin attenuates doxorubicin-induced cardiotoxicity.
Barış VÖ, Dinçsoy AB, Gedikli E, Zırh S, Müftüoğlu S, Erdem A. Barış VÖ, et al. Toxicol Res (Camb). 2023 Aug 31;12(5):998. doi: 10.1093/toxres/tfad071. eCollection 2023 Oct. Toxicol Res (Camb). 2023. PMID: 37915469 Free PMC article. No abstract available.
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial.
Mosele F, Deluche E, Lusque A, Le Bescond L, Filleron T, Pradat Y, Ducoulombier A, Pistilli B, Bachelot T, Viret F, Levy C, Signolle N, Alfaro A, Tran DTN, Garberis IJ, Talbot H, Christodoulidis S, Vakalopoulou M, Droin N, Stourm A, Kobayashi M, Kakegawa T, Lacroix L, Saulnier P, Job B, Deloger M, Jimenez M, Mahier C, Baris V, Laplante P, Kannouche P, Marty V, Lacroix-Triki M, Diéras V, André F. Mosele F, et al. Among authors: baris v. Nat Med. 2023 Aug;29(8):2110-2120. doi: 10.1038/s41591-023-02478-2. Epub 2023 Jul 24. Nat Med. 2023. PMID: 37488289 Free PMC article. Clinical Trial.
36 results